About the Authors
- Epke A. Le Rutte
-
Roles Conceptualization, Formal analysis, Investigation, Methodology, Visualization, Writing – original draft
* E-mail: e.lerutte@erasmusmc.nl
Affiliations Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands, Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland, University of Basel, Basel, Switzerland
- Luc E. Coffeng
-
Roles Methodology, Writing – review & editing
Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
- Stefano Malvolti
-
Roles Validation, Writing – review & editing
Affiliation MM Global Health Consulting, Zurich, Switzerland
- Paul M. Kaye
-
Roles Validation, Writing – review & editing
Affiliation York Biomedical Research Institute, Hull York Medical School, University of York, York, United Kingdom
- Sake J. de Vlas
-
Roles Conceptualization, Supervision, Writing – review & editing
Affiliation Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands
Competing Interests
I have read the journal's policy and the authors of this manuscript have the following competing interests: SM / MMGH received funding from the University of York to support the definition of a clinical development strategy and related business case for the vaccine candidate ChAd63-KH. PMK is funded by the Wellcome Trust (WT108518) and EDCTP (RIA2016V-1640) to develop a vaccine against leishmaniasis and is co-inventor of a patent covering a synthetic vaccine gene sequence (PCT/GB2010/000815).